Immunotherapy for Colorectal Cancer in the Era of Precision Medicine
Colorectal cancer (CRC) is considered the third most common cancer type and the second cause of cancer-related death worldwide, representing a significant global public health issue. Approximately 20% of patients present with metastatic disease, while up to 50% of those with early stages will eventu...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/82185 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Immunotherapy for Colorectal Cancer in the Era of Precision Medicine
- Treatment Modalities, Targeted Therapies, and Immunotherapy in Metastatic Colorectal Cancer
- Key Landmark Clinical Trials Transforming the Therapeutic Landscape of Metastatic Breast Cancer: From Precision Medicine to Immunotherapy
- Interventional Treatment of Colorectal Cancer with Traditional Chinese Medicine
- The New Era of Immunotherapy in Bile Duct Cancer Management
- Pharmacogenetics and Pharmacogenomics of Colorectal Cancer: Moving Towards Personalized Medicine
- Immunotherapy for Pancreatic Cancer